Abstract
Background: Two large-scale genome-wide association studies have identified rs610932 and rs670139 polymorphisms within the MS4A gene cluster as being significantly associated with susceptibility to Alzheimer’s disease (AD) in those with European ancestry. A number of studies have focused on the association between MS4A gene variants and AD in Caucasian and East Asian populations. However, the results remain inconsistent owing to the small sample size in each study.
Objective: We performed a meta-analysis to explore whether rs610932 and rs670139 polymorphisms are associated with susceptibility to AD. Method: 19 studies with 34,119 cases and 56,956 controls concerning rs610932 and 18 studies with 33,622 cases and 55,322 controls concerning rs670139 were included in this meta-analysis by searching the PubMed, MEDLINE, and AlzGene databases. Results: Our results showed significant associations between rs610932 and rs670139 polymorphisms and AD in the pooled population using an additive model. In subgroup analysis, we also identified a significant association of rs610932 in the Asian population under additive [odds ratio=0.82, 95% confidence interval 0.69-0.99, p=0.03] and dominant models (odds ratio=0.82, 95% confidence interval 0.72-0.95, p=0.006), but not under a recessive model. However, no association was found between rs670139 and AD patients using all three of these models in the Asian population. Conclusion: Our results suggest that the rs610932 polymorphism contributes to AD susceptibility in Caucasian and Asian populations. To our knowledge, this is the largest meta-analysis to investigate the association between MS4A gene polymorphisms and AD in Asian and European populations.Keywords: Alzheimer's disease, meta-analysis, MS4A gene cluster, rs610932, rs670139.
Current Alzheimer Research
Title:Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis
Volume: 14 Issue: 3
Author(s): Ruixia Zhu, Xu Liu and Zhiyi He
Affiliation:
Keywords: Alzheimer's disease, meta-analysis, MS4A gene cluster, rs610932, rs670139.
Abstract: Background: Two large-scale genome-wide association studies have identified rs610932 and rs670139 polymorphisms within the MS4A gene cluster as being significantly associated with susceptibility to Alzheimer’s disease (AD) in those with European ancestry. A number of studies have focused on the association between MS4A gene variants and AD in Caucasian and East Asian populations. However, the results remain inconsistent owing to the small sample size in each study.
Objective: We performed a meta-analysis to explore whether rs610932 and rs670139 polymorphisms are associated with susceptibility to AD. Method: 19 studies with 34,119 cases and 56,956 controls concerning rs610932 and 18 studies with 33,622 cases and 55,322 controls concerning rs670139 were included in this meta-analysis by searching the PubMed, MEDLINE, and AlzGene databases. Results: Our results showed significant associations between rs610932 and rs670139 polymorphisms and AD in the pooled population using an additive model. In subgroup analysis, we also identified a significant association of rs610932 in the Asian population under additive [odds ratio=0.82, 95% confidence interval 0.69-0.99, p=0.03] and dominant models (odds ratio=0.82, 95% confidence interval 0.72-0.95, p=0.006), but not under a recessive model. However, no association was found between rs670139 and AD patients using all three of these models in the Asian population. Conclusion: Our results suggest that the rs610932 polymorphism contributes to AD susceptibility in Caucasian and Asian populations. To our knowledge, this is the largest meta-analysis to investigate the association between MS4A gene polymorphisms and AD in Asian and European populations.Export Options
About this article
Cite this article as:
Zhu Ruixia, Liu Xu and He Zhiyi, Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer’s Disease: An Updated Meta-analysis, Current Alzheimer Research 2017; 14 (3) . https://dx.doi.org/10.2174/1567205013666161108110828
DOI https://dx.doi.org/10.2174/1567205013666161108110828 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autism: Pathophysiology and Promising Herbal Remedies
Current Pharmaceutical Design The Pharmacology of Aminoadamantane Nitrates
Current Alzheimer Research Regression to the Mean: Implications for Clinical Trials of Psychotropic Agents in Dementia
Current Alzheimer Research The Association and Influencing Factors between Antipsychotics Exposure and the Risk of VTE and PE: A Systematic Review and Meta-analysis
Current Drug Targets Nattokinase: An Updated Critical Review on Challenges and Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets 5-ht6 Receptors
Current Drug Targets - CNS & Neurological Disorders Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Current Topics in Medicinal Chemistry Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research General Anesthetics in Brain Injury: Friends or Foes?
Current Pharmaceutical Design Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects
Current Alzheimer Research Limonin, A Citrus Limonoid, had no Apparent Effect on Cognitive Dysfunction in Mice with Chronic Cerebral Hypoperfusion
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biomarkers of Alzheimer’s Disease: An Overview of the Recent Inventions
Recent Patents on Biomarkers Mechanisms of HIV-1 Tat Neurotoxicity via CDK5 Translocation and Hyper-Activation: Role in HIV-Associated Neurocognitive Disorders
Current HIV Research Trisubstituted Phenolic Compounds as Inhibitors of Acetylcholinesterase and Amyloid Beta Aggregate Formation
Current Enzyme Inhibition Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies
Current Alzheimer Research Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Association Between the Levels of Circulating Adhesion Molecules and Biopterins in Type-2 Diabetic Normotensive Patients Adhesion Molecules and Biopterins
Endocrine, Metabolic & Immune Disorders - Drug Targets Problems in Statistical Analysis of Attrition in Randomized Controlled Clinical Trials of Antidepressant for Geriatric Depression
Current Psychiatry Reviews Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
Current Topics in Medicinal Chemistry